Tower Research Capital (TRC)’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5K | Buy |
22,362
+4,854
| +28% | +$2.71K | ﹤0.01% | 3884 |
|
|
2025
Q1 | $8.33K | Buy |
17,508
+7,699
| +78% | +$3.67K | ﹤0.01% | 3900 |
|
|
2024
Q4 | $9.91K | Buy |
9,809
+2,709
| +38% | +$2.74K | ﹤0.01% | 3863 |
|
|
2024
Q3 | $12.1K | Sell |
7,100
-9,932
| -58% | -$17K | ﹤0.01% | 3615 |
|
|
2024
Q2 | $43.4K | Buy |
17,032
+12,676
| +291% | +$32.3K | ﹤0.01% | 3209 |
|
|
2024
Q1 | $18.2K | Buy |
4,356
+406
| +10% | +$1.7K | ﹤0.01% | 3080 |
|
|
2023
Q4 | $13.1K | Sell |
3,950
-23,901
| -86% | -$79.4K | ﹤0.01% | 3982 |
|
|
2023
Q3 | $55.7K | Buy |
27,851
+24,879
| +837% | +$49.8K | ﹤0.01% | 2454 |
|
|
2023
Q2 | $9.39K | Buy |
2,972
+760
| +34% | +$2.4K | ﹤0.01% | 4267 |
|
|
2023
Q1 | $8K | Sell |
2,212
-6,740
| -75% | -$24.4K | ﹤0.01% | 4636 |
|
|
2022
Q4 | $46K | Buy |
8,952
+4,795
| +115% | +$24.6K | ﹤0.01% | 2409 |
|
|
2022
Q3 | $41K | Buy |
4,157
+904
| +28% | +$8.92K | ﹤0.01% | 3336 |
|
|
2022
Q2 | $27K | Buy |
3,253
+2,459
| +310% | +$20.4K | ﹤0.01% | 3472 |
|
|
2022
Q1 | $10K | Sell |
794
-2,271
| -74% | -$28.6K | ﹤0.01% | 4316 |
|
|
2021
Q4 | $49K | Buy |
3,065
+2,468
| +413% | +$39.5K | ﹤0.01% | 2771 |
|
|
2021
Q3 | $15K | Buy |
+597
| New | +$15K | ﹤0.01% | 3979 |
|